| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.47 | 3e-18 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-12 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.35 | 5e-10 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |